Sort   by:  
 Page size 
UnknownLiquid biopsy approaches to capture tumor evolution and clinical outcomes during cancer immunotherapy.
Not available
S-EPMC9853269 | biostudies-literature
UnknownA prodrug-doped cellular Trojan Horse for the potential treatment of prostate cancer.
Not available
S-EPMC4824400 | biostudies-literature
UnknownClinical Features, Survival, and Burden of Toxicities in Survivors More Than One Year After Lung Cancer Immunotherapy.
Not available
S-EPMC9632301 | biostudies-literature
UnknownAssociation of Cardiovascular Health Through Young Adulthood With Genome-Wide DNA Methylation Patterns in Midlife: The CARDIA Study.
Not available
S-EPMC9348746 | biostudies-literature
UnknownCombined inhibition of SHP2 overcomes adaptive resistance to type 1 BRAF inhibitors in BRAF V600E-driven high-grade glioma.
Not available
S-EPMC12400027 | biostudies-literature
UnknownMultimodal genomic features predict outcome of immune checkpoint blockade in non-small-cell lung cancer.
Not available
S-EPMC7514475 | biostudies-literature
UnknownNeoadjuvant nivolumab plus ipilimumab in resectable non-small cell lung cancer.
Not available
S-EPMC7488786 | biostudies-literature
UnknownDevelopment and evaluation of a bladder Cancer specific survivorship care plan by patients and clinical care providers: a multi-methods approach.
Not available
S-EPMC7379822 | biostudies-literature
UnknownDeleterious heteroplasmic mitochondrial mutations are associated with an increased risk of overall and cancer-specific mortality.
Not available
S-EPMC10542802 | biostudies-literature
UnknownUser-Centered Design of a Preference-Driven Patient Activation Tool for Optimizing Depression Treatment in Integrated Primary Care Settings (The Transform DepCare Study).
Not available
S-EPMC11861791 | biostudies-literature
Sort   by:  
 Page size